Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS to Award Anticipated $14.8M to Princeton for Center of Excellence

NEW YORK, Aug. 31 (GenomeWeb News) - The National Institutes of General Medical Sciences said today that it has established a fifth Center of Excellence in Complex Biomedical Systems Research at Princeton University, awarding the university $3 million this year and as much as $14.8 million over the next five.

 

NIGMS, part of the National Institutes of Health, said the center will bring together 40 scientists from physical, computational, and biological science fields, and will establish at Princeton a new undergraduate and graduate curriculum that focuses on quantitative biology and collaborative research. David Botstein, professor of genomics at Princeton and director of the Lewis-Sigler Institute for Integrative Genomics at Princeton, will head the new center.

 

This will be the fifth such grant awarded by NIGMS, which established similar centers at Harvard and MIT last year, and at the University of Washington and CaseWestern ReserveUniversity in 2002.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.